Collective antibiotic resistance: Mechanisms and implications

Current Opinion in Microbiology

Volumn 21, Issue , 2014, Pages 28-34

  Vega, Nicole M ^a   Gore, Jeff ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BIOFILM; GENOTYPE; MICROBIAL COMMUNITY; NONHUMAN; PHENOTYPE; PHENOTYPIC VARIATION; POPULATION DYNAMICS; REVIEW; BACTERIUM; DRUG EFFECTS; ORGANISMAL INTERACTION; SIGNAL TRANSDUCTION;

ANTI-BACTERIAL AGENTS; BACTERIA; BIOFILMS; DRUG RESISTANCE, BACTERIAL; MICROBIAL INTERACTIONS; PHENOTYPE; SIGNAL TRANSDUCTION;

EID: 84907736803     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2014.09.003     Document Type: Review

References (57)

1. Hogan D., Kolter R. Why are bacteria refractory to antimicrobials?. Curr Opin Microbiol 2002, 5:472-477.
2. Tan C., Phillip Smith R., Srimani J.K., Riccione K.A., Prasada S., Kuehn M., You L. The inoculum effect and band-pass bacterial response to periodic antibiotic treatment. Mol Syst Biol 2012, 8:617. 10.1038/msb.2012.49.
3. Yurtsev E.A., Chao H.X., Datta M.S., Artemova T., Gore J. Bacterial cheating drives the population dynamics of cooperative antibiotic resistance plasmids. Mol Syst Biol 2013, 9. 10.1038/msb.2013.39.
4. Brook I. The role of beta-lactamase-producing-bacteria in mixed infections. BMC Infect Dis 2009, 9:202. 10.1186/1471-2334-9-202.
5. Andersson D.I., Hughes D. Persistence of antibiotic resistance in bacterial populations. FEMS Microbiol Rev 2011, 35:901-911. 10.1111/j.1574-6976.2011.00289.x.
6. Gullberg E., Cao S., Berg O.G., Ilbäck C., Sandegren L., Hughes D., Andersson D.I. Selection of resistant bacteria at very low antibiotic concentrations. PLoS Pathog 2011, 7:e1002158. 10.1371/journal.ppat.1002158.
7. Drescher K., Shen Y., Bassler B.L., Stone H.A. Biofilm streamers cause catastrophic disruption of flow with consequences for environmental and medical systems. Proc Natl Acad Sci U S A 2013, 110:4345-4350. 10.1073/pnas.1300321110.
8. Kirby A.E., Garner K., Levin B.R. The relative contributions of physical structure and cell density to the antibiotic susceptibility of bacteria in biofilms. Antimicrob Agents Chemother 2012, 56:2967-2975. 10.1128/AAC.06480-11.
9. Anderson G.G., O'Toole G.A. Innate and induced resistance mechanisms of bacterial biofilms. Bacterial Biofilms 2008, 85-105. Springer, Berlin, Heidelberg. 10.1007/978-3-540-75418-3_5. T. Romeo (Ed.).
10. Tseng B.S., Zhang W., Harrison J.J., Quach T.P., Song J.L., Penterman J., Singh P.K., Chopp D.L., Packman A.I., Parsek M.R. The extracellular matrix protects Pseudomonas aeruginosa biofilms by limiting the penetration of tobramycin. Environ Microbiol 2013, 15:2865-2878. 10.1111/1462-2920.12155.
11. Johnson L., Horsman S.R., Charron-Mazenod L., Turnbull A.L., Mulcahy H., Surette M.G., Lewenza S. Extracellular DNA-induced antimicrobial peptide resistance in Salmonella enterica serovar Typhimurium. BMC Microbiol 2013, 13:115. 10.1186/1471-2180-13-115.
12. Narisawa N., Haruta S., Arai H., Ishii M., Igarashi Y. Coexistence of antibiotic-producing and antibiotic-sensitive bacteria in biofilms is mediated by resistant bacteria. Appl Environ Microbiol 2008, 74:3887-3894. 10.1128/AEM.02497-07.
13. Nadell C.D., Bucci V., Drescher K., Levin S.A., Bassler B.L., Xavier J.B. Cutting through the complexity of cell collectives. Proc R Soc B: Biol Sci 2013, 280:20122770. 10.1098/rspb.2012.2770.
14. Hengzhuang W., Ciofu O., Yang L., Wu H., Song Z., Oliver A., Høiby N. High β-lactamase levels change the pharmacodynamics of β-lactam antibiotics in Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 2013, 57:196-204. 10.1128/AAC.01393-12.
15. Cook L.C., Dunny G.M. Effects of biofilm growth on plasmid copy number and expression of antibiotic resistance genes in Enterococcus faecalis. Antimicrob Agents Chemother 2013, 57:1850-1856. 10.1128/AAC.02010-12.
16. Stewart P.S., Franklin M.J. Physiological heterogeneity in biofilms. Nat Rev Microbiol 2008, 6:199-210. 10.1038/nrmicro1838.
17. Thomas J., Linton S., Corum L., Slone W., Okel T., Percival S.L. The affect of pH and bacterial phenotypic state on antibiotic efficacy. Int Wound J 2012, 9:428-435. 10.1111/j.1742-481X.2011.00902.x.
18. Wood T.K., Knabel S.J., Kwan B.W. Bacterial persister cell formation and dormancy. Appl Environ Microbiol 2013, 79:7116-7121. 10.1128/AEM.02636-13.
19. Nguyen D., Joshi-Datar A., Lepine F., Bauerle E., Olakanmi O., Beer K., McKay G., Siehnel R., Schafhauser J., Wang Y., et al. Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria. Science 2011, 334:982-986. 10.1126/science.1211037.
20. Amato S.M., Fazen C.H., Henry T.C., Mok W.W.K., Orman M.A., Sandvik E.L., Volzing K.G., Brynildsen M.P. The role of metabolism in bacterial persistence. Microb Physiol Metab 2014, 5:70. 10.3389/fmicb.2014.00070.
21. Dalton T., Dowd S.E., Wolcott R.D., Sun Y., Watters C., Griswold J.A., Rumbaugh K.P. An in vivo polymicrobial biofilm wound infection model to study interspecies interactions. PLoS ONE 2011, 6:e27317. 10.1371/journal.pone.0027317.
22. Brenner K., Arnold F.H. Self-organization, layered structure, and aggregation enhance persistence of a synthetic biofilm consortium. PLoS ONE 2011, 6:e16791. 10.1371/journal.pone.0016791.
23. Estrela S., Brown S.P. Metabolic and demographic feedbacks shape the emergent spatial structure and function of microbial communities. PLoS Comput Biol 2013, 9. 10.1371/journal.pcbi.1003398.
24. Popat R., Crusz S.A., Messina M., Williams P., West S.A., Diggle S.P. Quorum-sensing and cheating in bacterial biofilms. Proc R Soc B: Biol Sci 2012, 279:4765-4771. 10.1098/rspb.2012.1976.
25. Billings N., Ramirez Millan M., Caldara M., Rusconi R., Tarasova Y., Stocker R., Ribbeck K. The extracellular matrix component Psl provides fast-acting antibiotic defense in Pseudomonas aeruginosa biofilms. PLoS Pathog 2013, 9:e1003526. 10.1371/journal.ppat.1003526.
26. Kester J.C., Fortune S.M. Persisters and beyond: mechanisms of phenotypic drug resistance and drug tolerance in bacteria. Crit Rev Biochem Mol Biol 2014, 49:91-101. 10.3109/10409238.2013.869543.
27. Carlquist M., Fernandes R.L., Helmark S., Heins A.-L., Lundin L., Sørensen S.J., Gernaey K.V., Lantz A.E. Physiological heterogeneities in microbial populations and implications for physical stress tolerance. Microb Cell Fact 2012, 11:94. 10.1186/1475-2859-11-94.
28. Sufya N., Allison D.G., Gilbert P. Clonal variation in maximum specific growth rate and susceptibility towards antimicrobials. J Appl Microbiol 2003, 95:1261-1267. 10.1046/j.1365-2672.2003.02079.x.
29. Edwards A.M. Phenotype switching is a natural consequence of Staphylococcus aureus replication. J Bacteriol 2012, 194:5404-5412. 10.1128/JB.00948-12.
30. Balázsi G., van Oudenaarden A., Collins J.J. Cellular decision making and biological noise: from microbes to mammals. Cell 2011, 144:910-925. 10.1016/j.cell.2011.01.030.
31. Rotem E., Loinger A., Ronin I., Levin-Reisman I., Gabay C., Shoresh N., Biham O., Balaban N.Q. Regulation of phenotypic variability by a threshold-based mechanism underlies bacterial persistence. Proc Natl Acad Sci U S A 2010, 107:12541-12546. 10.1073/pnas.1004333107.
32. Deris J.B., Kim M., Zhang Z., Okano H., Hermsen R., Groisman A., Hwa T. The innate growth bistability and fitness landscapes of antibiotic-resistant bacteria. Science 2013, 342:1237435. 10.1126/science.1237435.
33. Kussell E., Leibler S. Phenotypic diversity, population growth, and information in fluctuating environments. Science 2005, 309:2075-2078. 10.1126/science.1114383.
34. Aldridge B.B., Fernandez-Suarez M., Heller D., Ambravaneswaran V., Irimia D., Toner M., Fortune S.M. Asymmetry and aging of mycobacterial cells lead to variable growth and antibiotic susceptibility. Science 2012, 335:100-104. 10.1126/science.1216166.
35. Arnoldini M., Mostowy R., Bonhoeffer S., Ackermann M. Evolution of stress response in the face of unreliable environmental signals. PLoS Comput Biol 2012, 8:e1002627. 10.1371/journal.pcbi.1002627.
36. Moker N., Dean C.R., Tao J. Pseudomonas aeruginosa increases formation of multidrug tolerant persister cells in response to quorum sensing signaling molecules. J Bacteriol 2010, 192:1946-1955. 10.1128/JB.01231-09.
37. Vega N.M., Allison K.R., Khalil A.S., Collins J.J. Signaling-mediated bacterial persister formation. Nat Chem Biol 2012, 8:431-433.
38. Vega N.M., Allison K.R., Samuels A.N., Klempner M.S., Collins J.J. Salmonella typhimurium intercepts Escherichia coli signaling to enhance antibiotic tolerance. Proc Natl Acad Sci U S A 2013, 110:14420-14425. 10.1073/pnas.1308085110.
39. Pereira C.S., Thompson J.A., Xavier K.B. AI-2-mediated signalling in bacteria. FEMS Microbiol Rev 2013, 37:156-181. 10.1111/j.1574-6976.2012.00345.x.
40. Lee H.H., Molla M.N., Cantor C.R., Collins J.J. Bacterial charity work leads to population-wide resistance. Nature 2010, 467:82-85.
41. Boyle K.E., Heilmann S., van Ditmarsch D., Xavier J.B. Exploiting social evolution in biofilms. Curr Opin Microbiol 2013, 16:207-212. 10.1016/j.mib.2013.01.003.
42. Böttcher T., Kolodkin-Gal I., Kolter R., Losick R., Clardy J. Synthesis and activity of biomimetic biofilm disruptors. J Am Chem Soc 2013, 135:2927-2930. 10.1021/ja3120955.
43. Foster K.R., Bell T. Competition, not cooperation, dominates interactions among culturable microbial species. Curr Biol 2012, 22:1845-1850. 10.1016/j.cub.2012.08.005.
44. Drescher K., Nadell C.D., Stone H.A., Wingreen N.S., Bassler B.L. Solutions to the public goods dilemma in bacterial biofilms. Curr Biol 2014, 24:50-55. 10.1016/j.cub.2013.10.030.
45. Nadell C.D., Xavier J.B., Foster K.R. The sociobiology of biofilms. FEMS Microbiol Rev 2009, 33:206-224. 10.1111/j.1574-6976.2008.00150.x.
46. Mina P., di Bernardo M., Savery N.J., Tsaneva-Atanasova K. Modelling emergence of oscillations in communicating bacteria: a structured approach from one to many cells. J R Soc Interface 2013, 10. 10.1098/rsif.2012.0612.
47. Cornforth D.M., Popat R., McNally L., Gurney J., Scott-Phillips T.C., Ivens A., Diggle S.P., Brown S.P. Combinatorial quorum sensing allows bacteria to resolve their social and physical environment. Proc Natl Acad Sci U S A 2014, 201319175. 10.1073/pnas.1319175111.
48. García-Contreras R., Maeda T., Wood T.K. Resistance to quorum quenching compounds. Appl Environ Microbiol 2013, 10.1128/AEM.02378-13.
49. Brook I. Microbiology of polymicrobial abscesses and implications for therapy. J Antimicrob Chemother 2002, 50:805-810. 10.1093/jac/dkg009.
50. Fischbach M.A. Combination therapies for combating antimicrobial resistance. Curr Opin Microbiol 2011, 14:519-523. 10.1016/j.mib.2011.08.003.
51. Lázár V., Pal Singh G., Spohn R., Nagy I., Horváth B., Hrtyan M., Busa-Fekete R., Bogos B., Méhi O., Csörgo B., et al. Bacterial evolution of antibiotic hypersensitivity. Mol Syst Biol 2013, 9. 10.1038/msb.2013.57.
52. Bollenbach T., Kishony R. Resolution of gene regulatory conflicts caused by combinations of antibiotics. Mol Cell 2011, 42:413-425. 10.1016/j.molcel.2011.04.016.
53. Torella J.P., Chait R., Kishony R. Optimal drug synergy in antimicrobial treatments. PLoS Comput Biol 2010, 6:e1000796. 10.1371/journal.pcbi.1000796.
54. Imamovic L., Sommer M.O.A. Use of collateral sensitivity networks to design drug cycling protocols that avoid resistance development. Sci Transl Med 2013, 5. 204ra132. 10.1126/scitranslmed.3006609.
55. Roy V., Adams B.L., Bentley W.E. Developing next generation antimicrobials by intercepting AI-2 mediated quorum sensing. Enzyme Microb Technol 2011, 49:113-123.
56. Allison K.R., Brynildsen M.P., Collins J.J. Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature 2011, 473:216-220. 10.1038/nature10069.
57. Orman M.A., Brynildsen M.P. Establishment of a method to rapidly assay bacterial persister metabolism. Antimicrob Agents Chemother 2013, 57:4398-4409. 10.1128/AAC.00372-13.